Promethos Capital, LLC Dr Reddys Laboratories LTD Transaction History
Promethos Capital, LLC
- $281 Billion
- Q3 2024
A detailed history of Promethos Capital, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Promethos Capital, LLC holds 134,734 shares of RDY stock, worth $2.12 Million. This represents 3.81% of its overall portfolio holdings.
Number of Shares
134,734
Previous 134,734
-0.0%
Holding current value
$2.12 Million
Previous $10.2 Billion
4.84%
% of portfolio
3.81%
Previous 3.87%
Shares
3 transactions
Others Institutions Holding RDY
# of Institutions
245Shares Held
23.1MCall Options Held
12.7KPut Options Held
6.1K-
Morgan Stanley New York, NY2.24MShares$35.2 Million0.01% of portfolio
-
Robeco Institutional Asset Management B.V.2.07MShares$32.4 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$31.3 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$30.6 Million0.25% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$28.3 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.61B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...